Fresenius Kabi Pharmaceuticals (APCVZ)

[d'anconia]

I'm curious as to what the float is as there are ~163.4 M shares O/S.

Here's the latest institutional & mutual fund ownership.

http://moneycentral.msn.com/ownership?Holding=Institutional+Ownership&Symbol=APCVZ

http://moneycentral.msn.com/ownership?Holding=Mutual+Fund+Ownership&Symbol=APCVZ

What's also noteworthy is the following.


http://www.fiercepharma.com/story/german-firm-pledges-4-6b-app-pharma/2008-07-07?utm_medium=rss&utm_source=rss&cmp-id=OTC-RSS-FP0

A German company is snapping up APP Pharmaceuticals in a deal worth more than $4.6 billion. Fresenius, an $18 billion company that sells products and services to hospitals and home healthcare groups, says the buyout will expand its presence in the lucrative U.S. market.
APP, you'll recall, has been in the news this year as the sole remaining U.S. producer of the blood thinner heparin. When Baxter saw its heparin production contaminated, it stopped making most of its heparin products; APP didn't have the same contamination problems, so it ramped up to try to fill the supply gap. APP also makes other injectables such as vitamin supplements, hormones, and diruretics.
An interesting side note: APP's recently-ex CEO Patrick Soon-Shiong owns some 83 percent of its stock, so you can bet he's saying ka-ching! Also CEO and a major investor in Abraxis BioScience, Soon-Shiong's share of the APP buyout could amount to as much as $3.8 billion if certain performance targets are met.


I'm not sure if ex CEO Patrick Soon-Shiong is restricted from selling his CVRs from the buyout. But if he hasn't sold, then this really reduces the float. At the very least, I think it would be safe to assume he still owns a sizable portion.

Forbes bio on Soon-Shiong

He's a billionaire and one of the richest men in the world.

http://people.forbes.com/profile/patrick-soon-shiong/623